Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Subjects With Chronic Stable Angina: A Phase 4 Randomized, Placebo-Controlled, Double-Blind, Cross-Over Study

Trial Profile

The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Subjects With Chronic Stable Angina: A Phase 4 Randomized, Placebo-Controlled, Double-Blind, Cross-Over Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Apr 2016

At a glance

  • Drugs Febuxostat (Primary)
  • Indications Angina pectoris
  • Focus Pharmacodynamics
  • Sponsors Takeda; Takeda Global Research and Development Center
  • Most Recent Events

    • 10 Mar 2016 Status changed from active, no longer recruiting to completed.
    • 07 Jan 2015 Planned End Date changed from 1 Sep 2014 to 1 Apr 2015 according to ClinicalTrials.gov record.
    • 07 Jan 2015 Planned primary completion date changed from 1 Sep 2014 to 1 Apr 2015 according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top